Gabriel Cabot

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 36

Top Topics

Pseudomonas Aeruginosa

Multidrug Resistant

Top Venues

Antimicrobial agents and chemotherapy

Microbiology spectrum

The Journal of antimicrobial chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

María Escobar-Salom, Isabel María Barceló, Estrella Rojo-Molinero, Elena Jordana-Lluch, Gabriel Cabot, Antonio Oliver, Carlos Juan
In vitro activity of human defensins HNP-1 and hBD-3 against multidrug-resistant ESKAPE Gram-negatives of clinical origin and selected peptidoglycan recycling-defective mutants. Microbiology spectrum 12 (4) (2024)
Isabel M Barceló, Maria Escobar-Salom, Gabriel Cabot, Pau Perelló-Bauzà, Elena Jordana-Lluch, Biel Taltavull, Gabriel Torrens, Estrella Rojo-Molinero, Laura Zamorano, Astrid Pérez, Antonio Oliver, Carlos Juan
Transferable AmpCs in Klebsiella pneumoniae : interplay with peptidoglycan recycling, mechanisms of hyperproduction, and virulence implications. Antimicrobial agents and chemotherapy (2024)
Isabel M Barceló, Maria Escobar-Salom, Gabriel Cabot, Pau Perelló-Bauzà, Elena Jordana-Lluch, Biel Taltavull, Gabriel Torrens, Estrella Rojo-Molinero, Laura Zamorano, Astrid Pérez, Antonio Oliver, Carlos Juan
Transferable AmpCs in Klebsiella pneumoniae : interplay with peptidoglycan recycling, mechanisms of hyperproduction, and virulence implications. Antimicrobial agents and chemotherapy 68 (5) (2024)
Isabel M Barceló, María Escobar-Salom, Gabriel Cabot, Pau Perelló-Bauzà, Elena Jordana-Lluch, Biel Taltavull, Gabriel Torrens, Estrella Rojo-Molinero, Laura Zamorano, Astrid Pérez, Antonio Oliver, Carlos Juan
Correction for Barceló et al., "Transferable AmpCs in Klebsiella pneumoniae : interplay with peptidoglycan recycling, mechanisms of hyperproduction, and virulence implications". Antimicrobial agents and chemotherapy 68 (7) (2024)
Isabel M Barceló, María Escobar-Salom, Gabriel Cabot, Pau Perelló-Bauzà, Elena Jordana-Lluch, Biel Taltavull, Gabriel Torrens, Estrella Rojo-Molinero, Laura Zamorano, Astrid Pérez, Antonio Oliver, Carlos Juan
Correction for Barceló et al., "Transferable AmpCs in Klebsiella pneumoniae : interplay with peptidoglycan recycling, mechanisms of hyperproduction, and virulence implications". Antimicrobial agents and chemotherapy (2024)
Ricardo Arcay, Maria Barceló-Nicolau, Loreto Suárez, Luisa Martín, Rebeca Reigada, Marcus Höring, Gerhard Liebisch, Carmen Garrido, Gabriel Cabot, Helem H Vilchez, Sara Cortés-Lara, Elisa González de Herrero, Carla López-Causapé, Antonio Oliver, Gwendolyn Barceló-Coblijn, Ana Mena
Gut microbiome and plasma lipidome analysis reveals a specific impact of Clostridioides difficile infection on intestinal bacterial communities and sterol metabolism. mBio (2024)
María Escobar-Salom, Isabel María Barceló, Estrella Rojo-Molinero, Elena Jordana-Lluch, Gabriel Cabot, Antonio Oliver, Carlos Juan
In vitro activity of human defensins HNP-1 and hBD-3 against multidrug-resistant ESKAPE Gram-negatives of clinical origin and selected peptidoglycan recycling-defective mutants. Microbiology spectrum (2024)
Isabel M Barceló, María Escobar-Salom, Gabriel Cabot, Pau Perelló-Bauzà, Elena Jordana-Lluch, Biel Taltavull, Gabriel Torrens, Estrella Rojo-Molinero, Laura Zamorano, Astrid Pérez, Antonio Oliver, Carlos Juan
Correction for Barceló et al., "Transferable AmpCs in Klebsiella pneumoniae : interplay with peptidoglycan recycling, mechanisms of hyperproduction, and virulence implications". Antimicrobial agents and chemotherapy 68 (7) (2024)
María Escobar-Salom, Isabel María Barceló, Estrella Rojo-Molinero, Elena Jordana-Lluch, Gabriel Cabot, Antonio Oliver, Carlos Juan
In vitro activity of human defensins HNP-1 and hBD-3 against multidrug-resistant ESKAPE Gram-negatives of clinical origin and selected peptidoglycan recycling-defective mutants. Microbiology spectrum 12 (4) (2024)
María Escobar-Salom, Isabel María Barceló, Estrella Rojo-Molinero, Elena Jordana-Lluch, Gabriel Cabot, Antonio Oliver, Carlos Juan
In vitro activity of human defensins HNP-1 and hBD-3 against multidrug-resistant ESKAPE Gram-negatives of clinical origin and selected peptidoglycan recycling-defective mutants. Microbiology spectrum 12 (4) (2024)
Isabel M Barceló, Maria Escobar-Salom, Gabriel Cabot, Pau Perelló-Bauzà, Elena Jordana-Lluch, Biel Taltavull, Gabriel Torrens, Estrella Rojo-Molinero, Laura Zamorano, Astrid Pérez, Antonio Oliver, Carlos Juan
Transferable AmpCs in Klebsiella pneumoniae : interplay with peptidoglycan recycling, mechanisms of hyperproduction, and virulence implications. Antimicrobial agents and chemotherapy 68 (5) (2024)
Isabel M Barceló, Maria Escobar-Salom, Gabriel Cabot, Pau Perelló-Bauzà, Elena Jordana-Lluch, Biel Taltavull, Gabriel Torrens, Estrella Rojo-Molinero, Laura Zamorano, Astrid Pérez, Antonio Oliver, Carlos Juan
Transferable AmpCs in Klebsiella pneumoniae : interplay with peptidoglycan recycling, mechanisms of hyperproduction, and virulence implications. Antimicrobial agents and chemotherapy 68 (5) (2024)
Isabel M Barceló, Maria Escobar-Salom, Gabriel Cabot, Pau Perelló-Bauzà, Elena Jordana-Lluch, Biel Taltavull, Gabriel Torrens, Estrella Rojo-Molinero, Laura Zamorano, Astrid Pérez, Antonio Oliver, Carlos Juan
Transferable AmpCs in Klebsiella pneumoniae : interplay with peptidoglycan recycling, mechanisms of hyperproduction, and virulence implications. Antimicrobial agents and chemotherapy 68 (5) (2024)
Gabriel Cabot, Ki-Hun Kim, Brian L Mark, Antonio Oliver, Mazdak Khajehpour
Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 67 (2) (2023)
Gabriel Cabot, Ki-Hun Kim, Brian L Mark, Antonio Oliver, Mazdak Khajehpour
Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 67 (2) (2023)
Gabriel Cabot, Ki-Hun Kim, Brian L Mark, Antonio Oliver, Mazdak Khajehpour
Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy (2023)
Gabriel Cabot, Ki-Hun Kim, Brian L Mark, Antonio Oliver, Mazdak Khajehpour
Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 67 (2) (2023)
Gabriel Cabot, Ki-Hun Kim, Brian L Mark, Antonio Oliver, Mazdak Khajehpour
Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 67 (2) (2023)
Gabriel Cabot, Ki-Hun Kim, Brian L Mark, Antonio Oliver, Mazdak Khajehpour
Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 67 (2) (2023)
Gabriel Cabot, Ki-Hun Kim, Brian L Mark, Antonio Oliver, Mazdak Khajehpour
Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 67 (2) (2023)
María A Gomis-Font, Miquel À Sastre-Femenia, Biel Taltavull, Gabriel Cabot, Antonio Oliver
In vitro dynamics and mechanisms of cefiderocol resistance development in wild-type, mutator and XDR Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy (2023)
María A Gomis-Font, Gabriel Cabot, Silvia López-Argüello, Laura Zamorano, Carlos Juan, Bartolome Moya, Antonio Oliver
Comparative analysis of in vitro dynamics and mechanisms of ceftolozane/tazobactam and imipenem/relebactam resistance development in Pseudomonas aeruginosa XDR high-risk clones. The Journal of antimicrobial chemotherapy 77 (4) (2022)
Isabel M Barceló, Elena Jordana-Lluch, María Escobar-Salom, Gabriel Torrens, Pablo A Fraile-Ribot, Gabriel Cabot, Xavier Mulet, Laura Zamorano, Carlos Juan, Antonio Oliver
Role of Enzymatic Activity in the Biological Cost Associated with the Production of AmpC β-Lactamases in Pseudomonas aeruginosa. Microbiology spectrum 10 (5) (2022)
Cristina Lasarte-Monterrubio, Pablo Arturo Fraile-Ribot, Juan Carlos Vázquez-Ucha, Gabriel Cabot, Paula Guijarro-Sánchez, Isaac Alonso-García, Soraya Rumbo-Feal, Fátima Galán-Sánchez, Alejandro Beceiro, Jorge Arca-Suárez, Antonio Oliver, Germán Bou
Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy 77 (10) (2022)
Isabel Barceló, Gabriel Cabot, Snehal Palwe, Prashant Joshi, Swapna Takalkar, Hariharan Periasamy, Sara Cortés-Lara, Laura Zamorano, Irina Sánchez-Diener, Bartolome Moya, Sachin S Bhagwat, Mahesh Patel, Antonio Oliver
In vitro evolution of cefepime/zidebactam (WCK 5222) resistance in Pseudomonas aeruginosa: dynamics, mechanisms, fitness trade-off and impact on in vivo efficacy. The Journal of antimicrobial chemotherapy 76 (10) (2021)
Andrew R Mack, Melissa D Barnes, Magdalena A Taracila, Andrea M Hujer, Kristine M Hujer, Gabriel Cabot, Michael Feldgarden, Daniel H Haft, William Klimke, Focco van den Akker, Alejandro J Vila, Andrea Smania, Shozeb Haider, Krisztina M Papp-Wallace, Patricia A Bradford, Gian Maria Rossolini, Jean-Denis Docquier, Jean-Marie Frère, Moreno Galleni, Nancy D Hanson, Antonio Oliver, Patrick Plésiat, Laurent Poirel, Patrice Nordmann, Timothy G Palzkill, George A Jacoby, Karen Bush, Robert A Bonomo
A Standard Numbering Scheme for Class C β-Lactamases. Antimicrobial agents and chemotherapy 64 (3) (2020)
Pablo A Fraile-Ribot, Laura Zamorano, Rocío Orellana, Ester Del Barrio-Tofiño, Irina Sánchez-Diener, Sara Cortes-Lara, Carla López-Causapé, Gabriel Cabot, Germán Bou, Luis Martínez-Martínez, Antonio Oliver, null null
Activity of Imipenem-Relebactam against a Large Collection of Pseudomonas aeruginosa Clinical Isolates and Isogenic β-Lactam-Resistant Mutants. Antimicrobial agents and chemotherapy 64 (2) (2020)
Jorge Arca-Suárez, Pablo Fraile-Ribot, Juan Carlos Vázquez-Ucha, Gabriel Cabot, Marta Martínez-Guitián, Emilio Lence, Concepción González-Bello, Alejandro Beceiro, Manuel Rodríguez-Iglesias, Fátima Galán-Sánchez, Germán Bou, Antonio Oliver
Challenging Antimicrobial Susceptibility and Evolution of Resistance (OXA-681) during Treatment of a Long-Term Nosocomial Infection Caused by a Pseudomonas aeruginosa ST175 Clone. Antimicrobial agents and chemotherapy 63 (10) (2019)
Bartolome Moya, Isabel M Barcelo, Gabriel Cabot, Gabriel Torrens, Snehal Palwe, Prashant Joshi, Kushal Umarkar, Swapna Takalkar, Hariharan Periasamy, Sachin Bhagwat, Mahesh Patel, German Bou, Antonio Oliver
In Vitro and In Vivo Activities of β-Lactams in Combination with the Novel β-Lactam Enhancers Zidebactam and WCK 5153 against Multidrug-Resistant Metallo-β-Lactamase-Producing Klebsiella pneumoniae. Antimicrobial agents and chemotherapy 63 (5) (2019)
Carla López-Causapé, Rosa Rubio, Gabriel Cabot, Antonio Oliver
Evolution of the Pseudomonas aeruginosa Aminoglycoside Mutational Resistome In Vitro and in the Cystic Fibrosis Setting. Antimicrobial agents and chemotherapy 62 (4) (2018)
Pablo A Fraile-Ribot, Xavier Mulet, Gabriel Cabot, Ester Del Barrio-Tofiño, Carlos Juan, José L Pérez, Antonio Oliver
In Vivo Emergence of Resistance to Novel Cephalosporin-β-Lactamase Inhibitor Combinations through the Duplication of Amino Acid D149 from OXA-2 β-Lactamase (OXA-539) in Sequence Type 235 Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 61 (9) (2017)
Ester Del Barrio-Tofiño, Carla López-Causapé, Gabriel Cabot, Alba Rivera, Natividad Benito, Concepción Segura, María Milagro Montero, Luisa Sorlí, Fe Tubau, Silvia Gómez-Zorrilla, Nuria Tormo, Raquel Durá-Navarro, Esther Viedma, Elena Resino-Foz, Marta Fernández-Martínez, Claudia González-Rico, Izaskun Alejo-Cancho, Jose Antonio Martínez, Cristina Labayru-Echverria, Carlos Dueñas, Ignacio Ayestarán, Laura Zamorano, Luis Martinez-Martinez, Juan Pablo Horcajada, Antonio Oliver
Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain. Antimicrobial agents and chemotherapy 61 (11) (2017)
Irina Sánchez-Diener, Laura Zamorano, Carla López-Causapé, Gabriel Cabot, Xavier Mulet, Carmen Peña, Rosa Del Campo, Rafael Cantón, Antonio Doménech-Sánchez, Luis Martínez-Martínez, Susana C Arcos, Alfonso Navas, Antonio Oliver
Interplay among Resistance Profiles, High-Risk Clones, and Virulence in the Caenorhabditis elegans Pseudomonas aeruginosa Infection Model. Antimicrobial agents and chemotherapy 61 (12) (2017)
Gabriel Cabot, Carla López-Causapé, Alain A Ocampo-Sosa, Lea M Sommer, María Ángeles Domínguez, Laura Zamorano, Carlos Juan, Fe Tubau, Cristina Rodríguez, Bartolomé Moyà, Carmen Peña, Luis Martínez-Martínez, Patrick Plesiat, Antonio Oliver
Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing. Antimicrobial agents and chemotherapy 60 (12) (2016)
Gabriel Torrens, Gabriel Cabot, Alain A Ocampo-Sosa, M Carmen Conejo, Laura Zamorano, Cristina Madrid, Álvaro Pascual, Luis Martínez-Martínez, Antonio Oliver
Activity of Ceftazidime-Avibactam against Clinical and Isogenic Laboratory Pseudomonas aeruginosa Isolates Expressing Combinations of Most Relevant β-Lactam Resistance Mechanisms. Antimicrobial agents and chemotherapy 60 (10) (2016)
Marcelo Pérez-Gallego, Gabriel Torrens, Jane Castillo-Vera, Bartolomé Moya, Laura Zamorano, Gabriel Cabot, Kjell Hultenby, Sebastián Albertí, Peter Mellroth, Birgitta Henriques-Normark, Staffan Normark, Antonio Oliver, Carlos Juan
Impact of AmpC Derepression on Fitness and Virulence: the Mechanism or the Pathway? mBio 7 (5) (2016)